Reliance On Grants

Recently I have noticed an interesting trend in the pages of The Scientist. Recognizing that the government plays an important role in their future, scientists are beginning to mobilize for greater involvement in the political process. In many ways, this can only be seen as a positive step. There is one aspect of this growing trend that troubles me, however. Whether it was the story on communicating with Congress by Robert Finn [page 14], the commentary by Raymond DuBois [page 10], or the lett

Written byMatthew Mcdonald
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Recently I have noticed an interesting trend in the pages of The Scientist. Recognizing that the government plays an important role in their future, scientists are beginning to mobilize for greater involvement in the political process. In many ways, this can only be seen as a positive step.

There is one aspect of this growing trend that troubles me, however. Whether it was the story on communicating with Congress by Robert Finn [page 14], the commentary by Raymond DuBois [page 10], or the letter by Eliot Brinton [page 11] (all published in the Sept. 16, 1996, issue of The Scientist), many seem to view greater government funding as the panacea for these competitive times.

Although government-funded research has been the hallmark of the last few decades, relying too heavily on grants is dangerous. Many in the United States feel that the economy is healthy and growing, albeit slowly. But is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies